-transparent.png){kind=logo}
Two definite acute hemolytic transfusion reactions occurred in a patient with chronic myelogenous leukemia in blastic crisis. Both suspect units were entirely compatible by routine crossmatch using commercial antiblobulin sera. However, both units were clearly incompatible using our own specific anti-C3 antiserum in the antiglobulin reaction phase of the crossmatch. Subsequently it was possible to predict in vivo compatibility using our anti-C3 antiserum in vitro. This case adds new evidence for the inadequacy of anticomplement activity in commercial antisera.
Related Publications
G K Sherwood, and
B F Haynes, and
W F Rosse
June 1991,
Transfusion,
G K Sherwood, and
B F Haynes, and
W F Rosse
January 2012,
Clinical & developmental immunology,
G K Sherwood, and
B F Haynes, and
W F Rosse
January 1962,
Transactions of the American Clinical and Climatological Association,
G K Sherwood, and
B F Haynes, and
W F Rosse
December 1959,
Ugeskrift for laeger,
G K Sherwood, and
B F Haynes, and
W F Rosse
January 1976,
Transfusion,
G K Sherwood, and
B F Haynes, and
W F Rosse
July 2010,
Transfusion,
G K Sherwood, and
B F Haynes, and
W F Rosse
August 1954,
Nordisk medicin,
G K Sherwood, and
B F Haynes, and
W F Rosse
April 1947,
The Lahey Clinic bulletin,
G K Sherwood, and
B F Haynes, and
W F Rosse
January 2008,
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie,
G K Sherwood, and
B F Haynes, and
W F Rosse
March 1964,
Canadian Medical Association journal,
